BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10942975)

  • 21. Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies.
    Sanmarco M; Gayet S; Alessi MC; Audrain M; de Maistre E; Gris JC; de Groot PG; Hachulla E; Harlé JR; Sié P; Boffa MC
    Thromb Haemost; 2007 Jun; 97(6):949-54. PubMed ID: 17549297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and heterogeneity of antiphosphatidylethanolamine antibodies in patients with recurrent early pregnancy losses.
    Sugi T; Katsunuma J; Izumi S; McIntyre JA; Makino T
    Fertil Steril; 1999 Jun; 71(6):1060-5. PubMed ID: 10360910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients.
    López-Soto A; Cervera R; Font J; Bové A; Reverter JC; Muñoz FJ; Miret C; Espinosa G; Ordinas A; Ingelmo M
    Clin Exp Rheumatol; 1997; 15(2):143-9. PubMed ID: 9196865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-phosphatidylethanolamine (aPE) antibodies: a survey.
    Mcintyre JA; Wagenknecht DR
    J Autoimmun; 2000 Sep; 15(2):185-93. PubMed ID: 10968907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma reactivity to hexagonal II phase phosphatidylethanolamine is more frequently associated with lupus anticoagulant than with antiphosphatidylethanolamine antibodies.
    Berard M; Boffa MC; Karmochkine M; Aillaud MF; Juhan-Vague I; Francès C; Cacoub P; Piette JC; Harlé JR
    J Lab Clin Med; 1993 Nov; 122(5):601-5. PubMed ID: 8228579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isotype distribution and clinical relevance of anti-beta2-glycoprotein I (beta2-GPI) antibodies: importance of IgA isotype.
    Lakos G; Kiss E; Regëczy N; Tarján P; Soltész P; Zeher M; Bodolay E; Szakony S; Sipka S; Szegedi G
    Clin Exp Immunol; 1999 Sep; 117(3):574-9. PubMed ID: 10469065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Classical and additional antiphospholipid antibodies in blood samples of ischemic stroke patients and healthy controls.
    Carmel-Neiderman NN; Tanne D; Goren I; Rotman-Pikielny P; Levy Y
    Immunol Res; 2017 Apr; 65(2):470-476. PubMed ID: 28116653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antiphosphatidylethanolamine antibody as a marker of antiphospholipid syndrome?].
    Yelnik CM; Dubucquoi S; Houfflin-Debarge V; Lambert M
    Presse Med; 2015 Mar; 44(3):284-91. PubMed ID: 25542711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome.
    Branch DW; Silver R; Pierangeli S; van Leeuwen I; Harris EN
    Obstet Gynecol; 1997 Apr; 89(4):549-55. PubMed ID: 9083311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical relevance of the IgM isotype of antiphospholipid antibodies in the vascular antiphospholipid syndrome.
    Del Ross T; Ruffatti A; Cuffaro S; Tonello M; Calligaro A; Favaro M; Facchinetti M; Hoxha A; Punzi L
    Thromb Res; 2015 Nov; 136(5):883-6. PubMed ID: 26410418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seronegative antiphospholipid syndrome.
    Nayfe R; Uthman I; Aoun J; Saad Aldin E; Merashli M; Khamashta MA
    Rheumatology (Oxford); 2013 Aug; 52(8):1358-67. PubMed ID: 23502076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the clinical relevance of anti-annexin-A5 antibodies in Chinese patients with antiphospholipid syndrome.
    Zhang S; Wu Z; Li J; Wen X; Li L; Zhang W; Zhao J; Zhang F; Li Y
    Clin Rheumatol; 2017 Feb; 36(2):407-412. PubMed ID: 28000012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between false-positive TORCH and antiphospholipid antibodies in healthy pregnant women.
    De Carolis S; Tabacco S; Rizzo F; Perrone G; Garufi C; Botta A; Salvi S; Benedetti Panici P; Lanzone A
    Lupus; 2018 Apr; 27(5):841-846. PubMed ID: 29157179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency and specificities of antiphospholipid antibodies (aPL) in volunteer blood donors.
    McIntyre JA; Wagenknech DR; Waxman DW
    Immunobiology; 2003; 207(1):59-63. PubMed ID: 12638905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antiphospholipid/cofactor syndromes: a primary variant with antibodies to beta 2-glycoprotein-I but no antibodies detectable in standard antiphospholipid assays.
    Cabral AR; Amigo MC; Cabiedes J; Alarcon-Segovia D
    Am J Med; 1996 Nov; 101(5):472-81. PubMed ID: 8948270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphospholipid syndrome diagnosis.
    Li R; Daguzan M; Vandermijnsbrugge F; Gyling M; Cantinieaux B
    Acta Clin Belg; 2014 Dec; 69(6):433-8. PubMed ID: 25103595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies to thromboplastin in systemic lupus erythematosus: isotype distribution and clinical significance in a series of 92 patients.
    Font J; López-Soto A; Cervera R; Casals FJ; Reverter JC; Muñoz FJ; Miret C; Bové A; Ordinas A; Ingelmo M
    Thromb Res; 1997 Apr; 86(1):37-48. PubMed ID: 9172285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative analysis of clinical and laboratory charactiristics of antiphospholipid syndrome].
    Soltész P; Veres K; Kiss E; Lakos G; Sonkoly I; Muszbek L; Szegedi G
    Orv Hetil; 2000 Dec; 141(52):2821-5. PubMed ID: 11202118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.